For citations:
Sviridenko N.Yu., Bessmertnaya E.G., Belovalova I.M., Sheremeta M.S., Babaeva D.M., Malysheva N.M., Troshina E.A., Melnichenko G.A. Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency. Medical Immunology (Russia). 2022;24(5):993-1006. (In Russ.) https://doi.org/10.15789/1563-0625-TGF-2514
Email this article 